Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $4.37 USD
Change Today 0.00 / 0.00%
Volume 0.0
ARNA On Other Exchanges
As of 8:10 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Dominic P. Behan Ph.D., D.Sc.

Co-Founder, Executive Vice President, Chief Scientific Officer, Director and Member of Science Committee, Arena Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Dominic P. Behan, Ph.D., D.Sc. is a co-founder of Arena Pharmaceuticals, Inc. and has been the Chief Scientific Officer and Executive Vice President since June 2004 and February 2012 respectively. Dr. Behan served as Senior Vice President of Arena Phawrmaceuticals, Inc., since June 2004. Dr. Behan served as Vice President of Research at Arena Pharmaceuticals, Inc. from April 1997 to June 2004. He has been Director of Arena Pharmaceuticals, Inc. since April 2000. ...

Read Full Background

Corporate Headquarters*

6154 Nancy Ridge Drive
San Diego, California 92121

United States

Phone: 858-453-7200
Fax: 858-453-7210

Board Members Memberships*

Co-Founder, Executive Vice President, Chief Scientific Officer, Director and Member of Science Committee


University of Reading
University of Leeds

Other Affiliations*

Annual Compensation*

Total Annual Compensation$420,000

Stock Options*

Restricted Stock Awards$1,290,600
All Other Compensation$16,041
Exercised Options200,000
Exercised Options Value$947,020
Exercisable Options471,448
Exercisable Options Value$608,400
Unexercisable Options725,000
Unexercisable Options Value$2,267,000
Total Value of Options$3,822,420
Total Number of Options1,396,448

Total Compensation*

Total Annual Cash Compensation$643,941
Total Short Term Compensation$420,000
Other Long Term Compensation$1,306,641
Total Calculated Compensation$2,326,831
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARNA:US $4.37 USD 0.00


Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
Raul R. Rodriguez Chief Executive Officer, President and Director
Rigel Pharmaceuticals, Inc.
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Michael A. Narachi M.S., M.B.A.Chief Executive Officer, President and Director
Orexigen Therapeutics, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARENA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at